Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intradermal, Fractional Dose of HPV Vaccines:
Sponsor: University of Washington
Summary
This randomized phase IV trial compares fractional dose of bivalent HPV vaccine to fractional dose of nonavalent HPV vaccine among men and women aged 27-45 years in Seattle, Washington. Participants will have immune response assessed at baseline, 4 weeks, 6 months, 12 months, and 24 months.
Official title: Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.
Key Details
Gender
All
Age Range
27 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2020-11-01
Completion Date
2026-12-31
Last Updated
2025-03-27
Healthy Volunteers
Yes
Conditions
Interventions
HPV vaccine
Gardasil 9 Bivalent HPV VLP Vaccine, one-fifth dose Nonavalent HPV VLP Vaccine, one-fifth dose
Locations (1)
University of Washington Virology Research Clinic
Seattle, Washington, United States